Skip to main content
Top
Published in: Tumor Biology 12/2015

Open Access 01-12-2015 | Research Article

The relationship between the expression of VEGF, EGFR, and HER-2 mRNA in esophageal squamous cell carcinoma (ESCC) and clinicopathological features of different ethnic groups in Xinjiang

Authors: Li Zhang, Yuling Wang, Ge Bai, Jianqing Zhang, Mei Yang, Xiaoli Ma

Published in: Tumor Biology | Issue 12/2015

Login to get access

Abstract

The purpose of this study was to explore the relationship between the expression of vascular endothelial growth factor (VEGF), human epidermal growth factor receptor 2 (HER-2), and epidermal growth factor receptor (EGFR) mRNA in esophageal squamous cell carcinoma (ESCC) and the clinicopathological characteristics of the Han, Uyghur, and Kazakh in Xinjiang. Real-time quantitative polymerase chain reaction technology (RT-PCR) was used to detect the expression of VEGF, HER-2, and EGFR mRNA in esophageal squamous cancer tissue of 60 cases and 30 cases of VEGF, HER-2, and EGFR mRNA in esophageal cancer adjacent tissues, and analyze its relationship with clinicopathological features. The results were as follows: (1) There was no statistically significant difference in esophageal tissue VEGF, HER-2, and EGFR mRNA gene expression levels of the Han, Uyghur, and Kazakh patients (P > 0.05). (2) The expression levels of VEGF, HER-2, and EGFR mRNA in ESCC group were higher than those in adjacent esophageal tissue group (P < 0.05). (3) The expression levels of VEGF and HER-2 mRNA in ESCC of the Han patients were higher than those of the Uyghur and Kazakh patients (P < 0.05). (4) The expression levels of VEGF, HER-2, and EGFR mRNA in lymph node metastases were higher than those without lymph node metastasis (P < 0.05). (5) The expression level of HER-2 mRNA was related with the degrees of pathological differentiation, and the higher pathologic degree, the lower expression level in HER-2 mRNA (P < 0.05). Therefore, the following conclusions were drawn: (1) There were ethnic differences in the VEGF and HER-2 gene mRNA expression levels of the Uyghur, Han, and Kazakh patients in Xinjiang. (2) The expressions of VEGF, HER-2, and EGFR mRNA were related to the lymph node metastasis in ESCC and pathologic differentiation degree.
Literature
1.
go back to reference Bray F, Ren JS, Masuyer E, et al. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132(5):1133–45.CrossRefPubMed Bray F, Ren JS, Masuyer E, et al. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132(5):1133–45.CrossRefPubMed
2.
go back to reference Luo W, Liu L, Shang X, et al. 2004–2005 Five counties in Xinjiang cancer mortality survey. Chin Chron Dis Prev Control. 2008;16(4):421–2. Luo W, Liu L, Shang X, et al. 2004–2005 Five counties in Xinjiang cancer mortality survey. Chin Chron Dis Prev Control. 2008;16(4):421–2.
3.
go back to reference Zhou F, Zhang L, Zhang L, et al. The clinical data analysis of 3,120 cases of esophageal cancer patients in Xinjiang. J Xinjiang Med Univ. 2010;4(33):418–21. Zhou F, Zhang L, Zhang L, et al. The clinical data analysis of 3,120 cases of esophageal cancer patients in Xinjiang. J Xinjiang Med Univ. 2010;4(33):418–21.
4.
go back to reference Zheng S, Liu T, Eziguli T, et al. The expressions of extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway in esophageal cancer tissue of Kazakh patients. Chin J Oncol. 2012;33(6):421–5. Zheng S, Liu T, Eziguli T, et al. The expressions of extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway in esophageal cancer tissue of Kazakh patients. Chin J Oncol. 2012;33(6):421–5.
5.
go back to reference Zhang L, Zhou Y, Cheng C, et al. Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma. Am J Hum Genet. 2015;96(4):597–611.CrossRefPubMedPubMedCentral Zhang L, Zhou Y, Cheng C, et al. Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma. Am J Hum Genet. 2015;96(4):597–611.CrossRefPubMedPubMedCentral
6.
go back to reference Li L, Yu Q, Li X, et al. The mechanism of gene 4 for loss of expression of esophageal cancer related gene in esophageal cancer cell line EC9706. Chin J Oncol. 2011;33(8):570–3. Li L, Yu Q, Li X, et al. The mechanism of gene 4 for loss of expression of esophageal cancer related gene in esophageal cancer cell line EC9706. Chin J Oncol. 2011;33(8):570–3.
8.
go back to reference Zhang L, Ma L-L, Zhang J-Q, et al. Comparisons of curative and side effects of chemoradiotherapy on esophageal carcinoma among Xinjiang Han, Uyghur and Kazakh patients. APJCP. 2012;13:169–73.PubMed Zhang L, Ma L-L, Zhang J-Q, et al. Comparisons of curative and side effects of chemoradiotherapy on esophageal carcinoma among Xinjiang Han, Uyghur and Kazakh patients. APJCP. 2012;13:169–73.PubMed
9.
go back to reference Sun J, Zhang L, Zhang J, et al. The expression levels of VEGF, EGFR, ES, HER-2, NF-kBp in serum of the Han and Uyghur ESCC patients in Xinjiang and clinical significance. J Xinjiang Med Univ. 2011;34(3):265–9. Sun J, Zhang L, Zhang J, et al. The expression levels of VEGF, EGFR, ES, HER-2, NF-kBp in serum of the Han and Uyghur ESCC patients in Xinjiang and clinical significance. J Xinjiang Med Univ. 2011;34(3):265–9.
10.
go back to reference Kitadai Y, Amioka, Haruma K, et al. Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas. Int J Cancer. 2001;93(5):662–6.CrossRefPubMed Kitadai Y, Amioka, Haruma K, et al. Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas. Int J Cancer. 2001;93(5):662–6.CrossRefPubMed
11.
go back to reference Lin D, Lin Y, Kuang L, et al. The study of the expression of VEGF in ESCC and angiopoietin-22 and clinical significance. Chin J Cancer Prev Treat. 2008;4(15):268–70. Lin D, Lin Y, Kuang L, et al. The study of the expression of VEGF in ESCC and angiopoietin-22 and clinical significance. Chin J Cancer Prev Treat. 2008;4(15):268–70.
12.
go back to reference Christian M, Jose F, Ingridb B, et al. VEGF-C expression in squamous cell carcinoma and adenocarcinoma of the esophagus. World J Surg. 2007;31(9):1768–72.CrossRef Christian M, Jose F, Ingridb B, et al. VEGF-C expression in squamous cell carcinoma and adenocarcinoma of the esophagus. World J Surg. 2007;31(9):1768–72.CrossRef
13.
go back to reference Wu X, Hedman H, Bergqvist M, et al. Expression of EGFR and LRIG proteins in oesophageal carcinoma with emphasis on patient survival and cellular chemosensitivity. Acta Oncol. 2012;51(1):69–76.CrossRefPubMed Wu X, Hedman H, Bergqvist M, et al. Expression of EGFR and LRIG proteins in oesophageal carcinoma with emphasis on patient survival and cellular chemosensitivity. Acta Oncol. 2012;51(1):69–76.CrossRefPubMed
14.
go back to reference Wang KL, Wu T-T, Choi IS, et al. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas. Am Cancer Soc. 2007;21(7):656–9. Wang KL, Wu T-T, Choi IS, et al. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas. Am Cancer Soc. 2007;21(7):656–9.
15.
go back to reference Gotoh M, Takiuchi H, Kawabe S, et al. Epidermal growth factor receptor is a possible predictor of sensitivity to chemoradiotherapy in the primary lesion of esophageal squamous cell carcinoma. Jpn J Clin Oncol. 2007;37(9):652–7.CrossRefPubMed Gotoh M, Takiuchi H, Kawabe S, et al. Epidermal growth factor receptor is a possible predictor of sensitivity to chemoradiotherapy in the primary lesion of esophageal squamous cell carcinoma. Jpn J Clin Oncol. 2007;37(9):652–7.CrossRefPubMed
16.
go back to reference Sato-Kuwabara Y, Neves JI, Fregnani JHTG, et al. Evaluation of gene amplification and protein expression of HER-2/neu in esophageal squamous cell carcinoma using fluorescence in situ hybridization (FISH) and immunohistochemistry. BMC Cancer. 2009;9(6):1–10. Sato-Kuwabara Y, Neves JI, Fregnani JHTG, et al. Evaluation of gene amplification and protein expression of HER-2/neu in esophageal squamous cell carcinoma using fluorescence in situ hybridization (FISH) and immunohistochemistry. BMC Cancer. 2009;9(6):1–10.
17.
go back to reference Deilich M, Wanders A, Brattsrom D, et al. HER-2 overexpression(3+) in patients with squamous cell esophageal carcinoma correlates with poorer survival. Dis Esophagus. 2006;19(4):224–31.CrossRef Deilich M, Wanders A, Brattsrom D, et al. HER-2 overexpression(3+) in patients with squamous cell esophageal carcinoma correlates with poorer survival. Dis Esophagus. 2006;19(4):224–31.CrossRef
18.
go back to reference Zhan N, Dong WG, et al. Analysis of HER-2 gene amplification and protein expression in esophageal squamous cell carcinoma. Med Oncol. 2011;2:1756–9. Zhan N, Dong WG, et al. Analysis of HER-2 gene amplification and protein expression in esophageal squamous cell carcinoma. Med Oncol. 2011;2:1756–9.
Metadata
Title
The relationship between the expression of VEGF, EGFR, and HER-2 mRNA in esophageal squamous cell carcinoma (ESCC) and clinicopathological features of different ethnic groups in Xinjiang
Authors
Li Zhang
Yuling Wang
Ge Bai
Jianqing Zhang
Mei Yang
Xiaoli Ma
Publication date
01-12-2015
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 12/2015
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-015-3656-z

Other articles of this Issue 12/2015

Tumor Biology 12/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine